Evidence map›Paper›PMID 36674264›Full record

ArticleInternational journal of environmental research and public health2023

Prevalence of Smoking Various Tobacco Types in the Kazakhstani Adult Population in 2021: A Cross-Sectional Study.

Natalya Glushkova, Dariga Smailova, Zhanar Namazbayeva, Gulmira Mukasheva, Ayaulym Zhamakurova, Asylzhan Kuanyshkalieva, Indira K Karibayeva, Almagul Kauysheva, Nurzhamal Otyzbayeva, Maksut Kulzhanov and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Mobilizing for Health: A Case Study of Kazakhstan's Vaping Ban Advocacy Campaign.International journal of environmental research and public health · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Natalya GlushkovaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.ORCID 0000-0003-1400-8436
Dariga SmailovaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Zhanar NamazbayevaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Gulmira MukashevaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Ayaulym ZhamakurovaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Asylzhan KuanyshkalievaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Indira K KaribayevaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Almagul KauyshevaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Nurzhamal OtyzbayevaDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Maksut KulzhanovDepartment of Epidemiology, Evidence Based Medicine and Biostatistics, Kazakhstan's Medical University "Kazakhstan School of Public Health", Almaty 050000, Kazakhstan.
Yuliya SemenovaDepartment of Medicine, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Kazakhstan Medical University · KZKazakh National Medical University · KZAl-Farabi Kazakh National University · KZNazarbayev University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco use was the second-leading risk factor for death, accounting for 15.4% of total deaths in 2019. In 2019, 20.4% (2.7 million) of the adult population in Kazakhstan, 36.5% of men, and 6.0% of women smoked tobacco. A cross-sectional study of a random sample (n = 1201) was conducted between October and December 2021 in accordance with the STEPwise approach. The tobacco-use questions were focused on current and previous smoking status, initiation and duration of smoking, amount of tobacco use, exposure to secondhand smoke, and information related to quitting smoking. From 20.8% of smokers, 93.8% of men and 80.2% of women use tobacco products daily, χ2 = 10.983, p-score < 0.001. The earliest initiation of smoking was 6 years old. The prevalence of smoking tobacco products in Kazakhstan is 20.8%, which means that every fifth adult smokes. In addition, the proportion of smokers among men was 38.5%, and among women, it was 10.1%. A total of 93.8% of men and 80.2% of women smoked daily. The role of healthcare professionals in smoking prevention is very low, and only 16.9% of respondents have been advised to quit smoking in the last 12 months. New interventions for tobacco smoking prevention are urgently needed in Kazakhstan.

Indexed as

Tobacco ProductsTobacco Smoke PollutionAdultChildCross-Sectional StudiesFemaleHumansMalePrevalenceSmokingTobacco UseTobacco Smoke Pollutiondaily tobacco smoking prevalenceKazakhstansmoking

Identifiers

PMID36674264
PMCPMC9865649
OpenAlexW4316371714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.